earnings

NASDAQ · ATRA
Atara Biotherapeutics, Inc.
Healthcare · Biotechnology
$7.70
Down-$0.23 (-2.90%)
Updated Nov 16, 2026, 4:04 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 128.72M
- P/E ratio
- 37.58
- Dividend yield
- 0.00%
- 52-week range
- $4.30 – $12.45
- Volume
- 17.04K
- Avg. volume
- 71.88K
Price performance · ATRA
ATRA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
ATRA closed at $7.70 after 20 trading sessions, down 14.06% for the selected period.
- Last close
- $7.70
- Period change
- -14.06%
- Period low
- $7.70
- Period high
- $9.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $7.63 | $7.795 | $7.46 | $7.70 | 17.04K |
| Nov 12, 2026 | $8.37 | $8.41 | $7.695 | $7.93 | 16.69K |
| Nov 11, 2026 | $8.10 | $8.37 | $7.94 | $8.23 | 10.34K |
| Nov 10, 2026 | $8.03 | $8.375 | $7.8001 | $8.10 | 33.14K |
| Nov 9, 2026 | $7.87 | $8.3136 | $7.6926 | $8.18 | 13.7K |
| Nov 6, 2026 | $7.86 | $8.00 | $7.74 | $7.87 | 16.3K |
| Nov 5, 2026 | $8.36 | $8.36 | $7.47 | $7.96 | 29.55K |
| Nov 4, 2026 | $8.25 | $8.525 | $8.25 | $8.37 | 9.48K |
| Nov 3, 2026 | $8.34 | $8.65 | $8.17 | $8.20 | 17.25K |
| Nov 2, 2026 | $8.05 | $8.59 | $8.02 | $8.48 | 32.05K |
| Oct 30, 2026 | $8.53 | $8.53 | $7.7231 | $8.01 | 29.96K |
| Oct 29, 2026 | $8.73 | $8.84 | $8.2602 | $8.53 | 11.87K |
| Oct 28, 2026 | $8.25 | $8.66 | $8.2201 | $8.66 | 26.85K |
| Oct 27, 2026 | $8.44 | $8.57 | $8.14 | $8.30 | 21.7K |
| Oct 26, 2026 | $8.68 | $8.68 | $8.10 | $8.35 | 35.27K |
| Oct 23, 2026 | $9.37 | $9.37 | $8.55 | $8.59 | 24.32K |
| Oct 22, 2026 | $9.23 | $9.65 | $8.9709 | $9.43 | 23.02K |
| Oct 21, 2026 | $9.25 | $9.43 | $9.17 | $9.35 | 26.54K |
| Oct 20, 2026 | $8.89 | $9.29 | $8.88 | $9.16 | 14.85K |
| Oct 19, 2026 | $9.03 | $9.35 | $8.96 | $8.96 | 12.45K |
Latest ATRA news
The latest Smart Investors Daily articles mentioning ATRA.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

